PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

NCT04243434 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Diseases

Interventions

DRUG: Vincristine Sulfate Liposome
COMBINATION_PRODUCT: CHOP
COMBINATION_PRODUCT: R-CHOP

Sponsor

Acrotech Biopharma Inc.

Collaborators

[object Object]